These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25131591)

  • 41. Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.
    Li X; James S; Lei P
    J Mol Neurosci; 2016 Nov; 60(3):298-304. PubMed ID: 27629562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease.
    Thome AD; Harms AS; Volpicelli-Daley LA; Standaert DG
    J Neurosci; 2016 Feb; 36(8):2383-90. PubMed ID: 26911687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease.
    Cardinale A; Calabrese V; de Iure A; Picconi B
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of α-synuclein in cognitive dysfunction: Studies in Drosophila melanogaster.
    Zhao X; Sun X; Cai S; Ran D; Yan Y; Pei Z
    Mol Med Rep; 2015 Aug; 12(2):2683-8. PubMed ID: 25954925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Interplay between Alpha-Synuclein Clearance and Spreading.
    Lopes da Fonseca T; Villar-Piqué A; Outeiro TF
    Biomolecules; 2015 Apr; 5(2):435-71. PubMed ID: 25874605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson's Disease via Protein Semisynthesis and Mutagenesis.
    Burai R; Ait-Bouziad N; Chiki A; Lashuel HA
    J Am Chem Soc; 2015 Apr; 137(15):5041-52. PubMed ID: 25768729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. α-Synuclein amino terminus regulates mitochondrial membrane permeability.
    Shen J; Du T; Wang X; Duan C; Gao G; Zhang J; Lu L; Yang H
    Brain Res; 2014 Dec; 1591():14-26. PubMed ID: 25446002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.
    Baksi S; Tripathi AK; Singh N
    Free Radic Biol Med; 2016 Aug; 97():292-306. PubMed ID: 27343690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new role for α-synuclein in Parkinson's disease: Alteration of ER-mitochondrial communication.
    Guardia-Laguarta C; Area-Gomez E; Schon EA; Przedborski S
    Mov Disord; 2015 Jul; 30(8):1026-33. PubMed ID: 25952565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The good and bad of therapeutic strategies that directly target α-synuclein.
    Longhena F; Faustini G; Brembati V; Pizzi M; Bellucci A
    IUBMB Life; 2020 Apr; 72(4):590-600. PubMed ID: 31693290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pink1 interacts with α-synuclein and abrogates α-synuclein-induced neurotoxicity by activating autophagy.
    Liu J; Wang X; Lu Y; Duan C; Gao G; Lu L; Yang H
    Cell Death Dis; 2017 Sep; 8(9):e3056. PubMed ID: 28933786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α-Synuclein impairs ferritinophagy in the retinal pigment epithelium: Implications for retinal iron dyshomeostasis in Parkinson's disease.
    Baksi S; Singh N
    Sci Rep; 2017 Oct; 7(1):12843. PubMed ID: 28993630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.
    Mazzulli JR; Zunke F; Isacson O; Studer L; Krainc D
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1931-6. PubMed ID: 26839413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. α-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading.
    Loria F; Vargas JY; Bousset L; Syan S; Salles A; Melki R; Zurzolo C
    Acta Neuropathol; 2017 Nov; 134(5):789-808. PubMed ID: 28725967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis.
    Gadhe L; Sakunthala A; Mukherjee S; Gahlot N; Bera R; Sawner AS; Kadu P; Maji SK
    Biophys Chem; 2022 Feb; 281():106736. PubMed ID: 34923391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exosomes from patients with Parkinson's disease are pathological in mice.
    Han C; Xiong N; Guo X; Huang J; Ma K; Liu L; Xia Y; Shen Y; Li J; Jiang H; Wang L; Guo S; Xu X; Zhang G; Liu J; Cao X; Zhang Z; Lin Z; Wang T
    J Mol Med (Berl); 2019 Sep; 97(9):1329-1344. PubMed ID: 31302715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What can trigger the onset of Parkinson's disease - A modeling study based on a compartmental model of α-synuclein transport and aggregation in neurons.
    Kuznetsov IA; Kuznetsov AV
    Math Biosci; 2016 Aug; 278():22-9. PubMed ID: 27211070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GRP78 clustering at the cell surface of neurons transduces the action of exogenous alpha-synuclein.
    Bellani S; Mescola A; Ronzitti G; Tsushima H; Tilve S; Canale C; Valtorta F; Chieregatti E
    Cell Death Differ; 2014 Dec; 21(12):1971-83. PubMed ID: 25124556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease.
    Rostovtseva TK; Gurnev PA; Protchenko O; Hoogerheide DP; Yap TL; Philpott CC; Lee JC; Bezrukov SM
    J Biol Chem; 2015 Jul; 290(30):18467-77. PubMed ID: 26055708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
    Wang X; Yu S; Li F; Feng T
    Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.